Sabra Healthcare REIT saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 77 to 81.
IBD's proprietary RS Rating tracks technical performance by showing how a stock's price action over the last 52 weeks measures up against that of other stocks on the major indexes.
Decades of market research shows that the stocks that go on to make the biggest gains often have an RS Rating of above 80 as they begin their biggest climbs.
Risk Management In The Stock Market: How Much Money To Invest Now
While it's not currently an ideal time to buy shares, see if the stock manages to establish and enter a buy zone in heavy trade.
While EPS growth declined in the company's most recently reported quarter from 9% to 6%, revenue rose 12%, up from 10% in the prior report.
Sabra Healthcare REIT holds the No. 11 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT, Strawberry Fields REIT and Curbline Properties are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
